Genematrix Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
7,291
6,676
5,315
5,080
5,189
Cost of Goods Sold (COGS) incl. D&A
4,378
4,138
3,218
3,439
3,560
Gross Income
2,912
2,539
2,097
1,641
1,629
SG&A Expense
4,330
3,861
4,265
5,622
3,391
EBIT
1,418
1,322
2,168
3,981
1,762
Unusual Expense
-
-
254
44
-
Non Operating Income/Expense
44
183
103
29
8
Interest Expense
162
147
197
248
97
Pretax Income
1,442
1,114
2,384
4,085
1,735
Consolidated Net Income
1,442
1,114
2,384
4,085
1,735
Net Income
1,492
1,123
2,020
3,777
1,470
Net Income After Extraordinaries
1,492
1,123
2,020
3,777
1,470
Net Income Available to Common
1,492
1,123
2,020
3,777
1,470
EPS (Basic)
119.00
90.00
160.67
278.00
96.00
Basic Shares Outstanding
13
13
13
14
15
EPS (Diluted)
119.01
89.70
160.96
278.11
95.92
Diluted Shares Outstanding
13
13
13
14
15
EBITDA
807
732
1,660
3,593
1,433
Non-Operating Interest Income
182
172
132
159
133
Minority Interest Expense
51
9
364
308
265

About Genematrix

View Profile
Address
7 to 8th Floor, Korea Bio Park Bldg
Seongnam GY 13488
Korea, Republic Of
Employees -
Website http://www.genematrix.net
Updated 09/14/2018
GENEMATRIX, Inc. engages in the development of platform and molecular diagnostics products. Its products include pharmaceutical products for hepatology, sexually transmited diseaseds, genetic diseases, and others. The company was founded in December 7, 2000 and is headquartered in Seongnam, South Korea.